Bzeizi, K.I.; Arabi, M.; Jamshidi, N.; Albenmousa, A.; Sanai, F.M.; Al-Hamoudi, W.; Alghamdi, S.; Broering, D.; Alqahtani, S.A.
Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cancers 2021, 13, 6172.
https://doi.org/10.3390/cancers13246172
AMA Style
Bzeizi KI, Arabi M, Jamshidi N, Albenmousa A, Sanai FM, Al-Hamoudi W, Alghamdi S, Broering D, Alqahtani SA.
Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cancers. 2021; 13(24):6172.
https://doi.org/10.3390/cancers13246172
Chicago/Turabian Style
Bzeizi, Khalid I., Mohammad Arabi, Negar Jamshidi, Ali Albenmousa, Faisal M. Sanai, Waleed Al-Hamoudi, Saad Alghamdi, Dieter Broering, and Saleh A. Alqahtani.
2021. "Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis" Cancers 13, no. 24: 6172.
https://doi.org/10.3390/cancers13246172
APA Style
Bzeizi, K. I., Arabi, M., Jamshidi, N., Albenmousa, A., Sanai, F. M., Al-Hamoudi, W., Alghamdi, S., Broering, D., & Alqahtani, S. A.
(2021). Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cancers, 13(24), 6172.
https://doi.org/10.3390/cancers13246172